The EMT transcription factor TWIST1 mediates resistance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

被引：1
|
作者：
Yochum, Zachary A.
Wang, Hailun
Cades, Jessica A.
Khetarpal, Susheel
Huang, Eric H.
Tran, Phouc T.
Burns, Timothy F.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4118
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4118
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Patritumab Deruxtecan Is Efficacious in EGFR-Mutant Non-Small Cell Lung Cancer
    Zhang, H.
    Yu, X.
    Ye, J.
    Li, H.
    Hu, J.
    Tan, Y.
    [J]. CANCER DISCOVERY, 2023, 13 (12) : 2501 - 2501
  • [22] ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer
    Desai, Aakash
    Vazquez, Tadana A.
    Arce, Keishla M.
    Corassa, Marcelo
    Mack, Philip C.
    Gray, Jhanelle E.
    Pellini, Bruna
    [J]. CANCERS, 2024, 16 (05)
  • [23] The BIM Deletion Polymorphism in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors
    Lee, Ji Yun
    Ku, Bo Mi
    Lim, Sung Hee
    Kim, Haesu
    Yoo, Kwai Han
    Jung, Ki Sun
    Song, Haa-Na
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S580 - S580
  • [24] Activation of AURKA contributes to TKI resistance in EGFR-mutant non-small lung cancer
    Lee, Meng-Hsuan
    Hong, Shiao-Ya
    Kao, Yu-Rung
    Wu, Cheng-Wen
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [25] Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
    Xia, Jinjing
    Bai, Hao
    Yan, Bo
    Li, Rong
    Shao, Minhua
    Xiong, Liwen
    Han, Baohui
    [J]. ONCOTARGET, 2017, 8 (65) : 108522 - 108533
  • [26] Endothelin-1-Mediated Drug Resistance in EGFR-Mutant Non-Small Cell Lung Carcinoma
    Pulido, Ines
    Ollosi, Stephen
    Aparisi, Salvador
    Becker, Jeffrey H.
    Aliena-Valero, Alicia
    Benet, Marta
    Rodriguez, Maria L.
    Lopez, Adrian
    Tamayo-Torres, Eva
    Chulia-Peris, Lourdes
    Garcia-Canaveras, Juan Carlos
    Soucheray, Margaret
    Dalheim, Annika, V
    Salom, Juan B.
    Qiu, Wei
    Kaja, Simon
    Fernandez-Coronado, Javier Alcacer
    Alandes, Sandra
    Alcacer, Javier
    Al-Shahrour, Fatima
    Borgia, Jeffrey A.
    Juan, Oscar
    Nishimura, Michael, I
    Lahoz, Agustin
    Carretero, Julian
    Shimamura, Takeshi
    [J]. CANCER RESEARCH, 2020, 80 (19) : 4224 - 4232
  • [27] ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer
    Ortega-Franco, Ana
    Rafee, Shereen
    [J]. ONCOLOGY AND THERAPY, 2022, 10 (01) : 13 - 22
  • [28] Significance of immune checkpoint proteins in EGFR-mutant non-small cell lung cancer
    Soo, Ross A.
    Kim, Hye Ryun
    Asuncion, Bernadette Reyna
    Fazreen, Zul
    Omar, Mohamed Feroz Mohd
    Herrera, Maria Cynthia
    Lim, Joey Sze Yun
    Sia, Grace
    Soong, Richie
    Cho, Byoung-Chul
    [J]. LUNG CANCER, 2017, 105 : 17 - 22
  • [29] ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer
    Ana Ortega-Franco
    Shereen Rafee
    [J]. Oncology and Therapy, 2022, 10 : 13 - 22
  • [30] Radiomic Signature to Predict Outcomes in EGFR-Mutant Non-Small Cell Lung Cancer
    Minatta, J. N.
    Deza, D.
    Aineseder, M.
    Nunez, M. Mestas
    Mosquera, C.
    Lupinacci, L.
    Benitez, S.
    Seehaus, A.
    Luna, D.
    Beresnak, A.
    Diaz, F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1166 - S1166
12345